Filtros : "Bender, Eduardo A" Limpar

Filtros



Refine with date range


  • Source: Pharmaceutical Research. Unidade: FCF

    Subjects: NANOPARTÍCULAS, LIPOPROTÉINAS LDL

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BENDER, Eduardo A et al. New strategy to surface functionalization of polymeric nanoparticles: one-pot synthesis of scFv anti-LDL(−) -functionalized nanocapsules. Pharmaceutical Research, v. 31, n. 11, p. 2975-2987, 2014Tradução . . Disponível em: https://doi.org/10.1007/s11095-014-1392-5. Acesso em: 10 jun. 2024.
    • APA

      Bender, E. A., Cavalcante, M. F., Adorne, M. D., Colomé, L. M., Guterres, S. S., Abdalla, D. S. P., & Adriana R. Pohlmann,. (2014). New strategy to surface functionalization of polymeric nanoparticles: one-pot synthesis of scFv anti-LDL(−) -functionalized nanocapsules. Pharmaceutical Research, 31( 11), 2975-2987. doi:10.1007/s11095-014-1392-5
    • NLM

      Bender EA, Cavalcante MF, Adorne MD, Colomé LM, Guterres SS, Abdalla DSP, Adriana R. Pohlmann. New strategy to surface functionalization of polymeric nanoparticles: one-pot synthesis of scFv anti-LDL(−) -functionalized nanocapsules [Internet]. Pharmaceutical Research. 2014 ; 31( 11): 2975-2987.[citado 2024 jun. 10 ] Available from: https://doi.org/10.1007/s11095-014-1392-5
    • Vancouver

      Bender EA, Cavalcante MF, Adorne MD, Colomé LM, Guterres SS, Abdalla DSP, Adriana R. Pohlmann. New strategy to surface functionalization of polymeric nanoparticles: one-pot synthesis of scFv anti-LDL(−) -functionalized nanocapsules [Internet]. Pharmaceutical Research. 2014 ; 31( 11): 2975-2987.[citado 2024 jun. 10 ] Available from: https://doi.org/10.1007/s11095-014-1392-5
  • Source: International Journal of Pharmaceutics. Unidade: FCF

    Subjects: NANOPARTÍCULAS, LECITINAS, QUITOSANA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BENDER, Eduardo A et al. Hemocompatibility of poly(ε-caprolactone) lipid-core nanocapsules stabilized with polysorbate 80-lecithin and uncoated or coated with chitosan. International Journal of Pharmaceutics, v. 426, n. 1-2, p. 271-279, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2012.01.051. Acesso em: 10 jun. 2024.
    • APA

      Bender, E. A., Adorne, M. D., Colomé, L. M., Abdalla, D. S. P., Guterres, S. S., & Pohlmann, A. R. (2012). Hemocompatibility of poly(ε-caprolactone) lipid-core nanocapsules stabilized with polysorbate 80-lecithin and uncoated or coated with chitosan. International Journal of Pharmaceutics, 426( 1-2), 271-279. doi:10.1016/j.ijpharm.2012.01.051
    • NLM

      Bender EA, Adorne MD, Colomé LM, Abdalla DSP, Guterres SS, Pohlmann AR. Hemocompatibility of poly(ε-caprolactone) lipid-core nanocapsules stabilized with polysorbate 80-lecithin and uncoated or coated with chitosan [Internet]. International Journal of Pharmaceutics. 2012 ; 426( 1-2): 271-279.[citado 2024 jun. 10 ] Available from: https://doi.org/10.1016/j.ijpharm.2012.01.051
    • Vancouver

      Bender EA, Adorne MD, Colomé LM, Abdalla DSP, Guterres SS, Pohlmann AR. Hemocompatibility of poly(ε-caprolactone) lipid-core nanocapsules stabilized with polysorbate 80-lecithin and uncoated or coated with chitosan [Internet]. International Journal of Pharmaceutics. 2012 ; 426( 1-2): 271-279.[citado 2024 jun. 10 ] Available from: https://doi.org/10.1016/j.ijpharm.2012.01.051

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024